Financhill
Buy
66

VRTX Quote, Financials, Valuation and Earnings

Last price:
$476.80
Seasonality move :
4.65%
Day range:
$465.00 - $479.12
52-week range:
$362.50 - $519.68
Dividend yield:
0%
P/E ratio:
31.10x
P/S ratio:
10.19x
P/B ratio:
6.49x
Volume:
1M
Avg. volume:
1.6M
1-year change:
-0.71%
Market cap:
$121.1B
Revenue:
$12.1B
EPS (TTM):
$15.33

Earnings Data

Next earnings date for VRTX
May 04
2026
Most recent earnings per share
$4.65
Missed by $0.50
(Feb 12/2026)
Consensus Estimate
$5.15
(Feb 12/2026)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VRTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/04/2026 Q1 $3.1B -- -- $4.41 --
02/12/2026 Q4 $3.2B $3.2B $4.65 $5.15 -$0.50
11/03/2025 Q3 $3.1B $3.1B $4.20 $4.58 -$0.37
08/04/2025 Q2 $2.9B $3B $3.99 $4.25 -$0.26
05/05/2025 Q1 $2.9B $2.7B $2.49 $4.29 -$1.80
02/10/2025 Q4 $2.8B $2.9B $3.50 $4.02 -$0.52
11/04/2024 Q3 $2.7B $2.8B $4.01 $4.13 -$0.13
08/01/2024 Q2 $2.7B $2.6B -$13.92 -$11.75 -$2.17
05/06/2024 Q1 $2.6B $2.7B $4.21 $4.06 $0.15
02/05/2024 Q4 $2.5B $2.5B $3.71 $4.09 -$0.37
11/06/2023 Q3 -- $2.5B $3.97 -- --
08/01/2023 Q2 -- $2.5B $3.52 -- --
05/01/2023 Q1 -- $2.4B $2.69 -- --
02/07/2023 Q4 -- $2.3B $3.15 -- --
10/27/2022 Q3 -- $2.3B $3.59 -- --
08/04/2022 Q2 -- $2.2B $3.13 -- --
05/05/2022 Q1 -- $2.1B $2.96 -- --
01/26/2022 Q4 -- $2.1B $3.00 -- --
11/02/2021 Q3 -- $2B $3.28 -- --
07/29/2021 Q2 -- $1.8B $0.26 -- --
04/29/2021 Q1 -- $1.7B $2.49 -- --
02/01/2021 Q4 -- $1.6B $2.30 -- --
10/29/2020 Q3 -- $1.5B $2.53 -- --
07/30/2020 Q2 -- $1.5B $3.18 -- --
04/29/2020 Q1 -- $1.5B $2.29 -- --
01/30/2020 Q4 -- $1.4B $2.23 -- --
10/30/2019 Q3 -- $939.5M $0.22 -- --
07/31/2019 Q2 -- $933.1M $1.03 -- --
04/30/2019 Q1 -- $851.6M $1.03 -- --
02/05/2019 Q4 -- $863.9M $5.97 -- --
10/24/2018 Q3 -- $782.8M $0.50 -- --
07/25/2018 Q2 -- $754.8M $0.80 -- --
04/26/2018 Q1 -- $640.8M $0.81 -- --
01/31/2018 Q4 -- $651.6M $0.39 -- --
10/25/2017 Q3 -- $578.2M -$0.41 -- --
07/26/2017 Q2 -- $542.2M $0.07 -- --
04/27/2017 Q1 -- $714.7M $0.99 -- --
01/25/2017 Q4 -- $458.7M $0.13 -- --
10/25/2016 Q3 -- $413.8M -$0.16 -- --
07/27/2016 Q2 -- $431.6M -$0.26 -- --
04/27/2016 Q1 -- $398.1M -$0.17 -- --

Vertex Pharmaceuticals, Inc. Earnings Questions

  • How Much did Vertex Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Vertex Pharmaceuticals, Inc. reported $3.2B worth of top line sales in its most recent quarter.

  • Did Vertex Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Vertex Pharmaceuticals, Inc. announced earnings per share of $4.65 which represents a miss of analyst forecast a $5.15 per share.

  • Is Vertex Pharmaceuticals, Inc. Profitable?

    Vertex Pharmaceuticals, Inc. reported $2.8B that represents $10.78 per share over the last quarter.

  • What is the Analyst Consensus for Vertex Pharmaceuticals, Inc. EPS Next Year?

    Vertex Pharmaceuticals, Inc.'s earnings are forecast to grow from $15.32 per share to $18.43 per share next year representing an increase of 25.32%.

  • When is Vertex Pharmaceuticals, Inc.'s Earnings Date?

    Vertex Pharmaceuticals, Inc.'s next earnings date is May 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock